000			02886nam a22003617u 4500
001			pwiiw7400
003			OSt
005			20260518120019.0
008			250922t2025 au ||||| |||| 00| ||eng d
040			_cOSt
041			_aeng
084			_aF14 _aF23 _aL64 _aO14 _2jelc
100	1		_aFrancis, Smitha
245	1	0	_aPost-pandemic shifts in medical electronics GVCs and changing value dynamics amidst new digitalisation: An analysis based on Indian subsidiaries of EU-based corporations
260			_aWien : _bWiener Institut für Internationale Wirtschaftsvergleiche (wiiw), _c2025.
300			_a59 S., _b13 Tables and 29 Figures, _c30cm.
490	1		_awiiw Research Reports _v479
520			_aRealignments of global value chains (GVCs) are occurring at a time when the technological dynamics in manufacturing industries, including in healthcare-related industries like medical electronics, is undergoing significant changes due to the wave of new digitalisation. This study examines post-pandemic changes in global medical electronics value chains through industry-level trade analysis and the GVC participation of selected Indian subsidiaries of medical electronics companies based in the European Union (EU), focusing on the implications of digitalisation and data-centric strategies for capturing value. The study finds that post-COVID-19 realignments in the industry proceeded gradually until 2023. Meanwhile, digitalisation is leading to a gradual expansion in operations by EU-based medical device multinational corporations (MNCs) in India. This is shown to be due to the increased role of software for product design and process optimisation in digitalising value chains. Leading EU-based medical device MNCs are found to be leveraging India’s strengths in software design and data-analytics capabilities for co-developing their software-embedded ‘health systems’ and ‘solutions’. However, even when software and services exports from India went up with increasing digitalisation, the shares of the EU-based lead firm groups in total revenue of the Indian subsidiaries were found to increase. This occurred through imports of software-embedded medical devices and equipment along with imports of higher-valued proprietary software platforms, health systems and the like, which are patented and marketed by the EU-based lead firms or their foreign subsidiaries back to India.
650			_adigitalisation
650			_aGVCs
650			_amedical device industry
650			_amedical electronics
650			_aEuropean MNCs
650			_avalue distribution
650			_adigital value chains
651			_aEuropean Union
651			_aIndia
690			_aInternational Trade, Competitiveness and FDI
690			_aSectoral studies
830		0	_v479 _wWIIW0000048 _twiiw Research Reports
856	4	0	_uhttps://wiiw.ac.at/p-7400.html
942			_cP
999			_c9144 _d9144